Every change Olive tracked that week for importers and exporters, each with its official source.
2 changes
FDA announces issuance of a priority review voucher to the sponsor of the rare pediatric disease product ISEMBYLD (apitegromab-mstn), now approved.
USTR proposes extending the suspension of Section 301 action on China's maritime, logistics, and shipbuilding sectors through January 9, 2027, and invites public comments.
Olive reads every change like these against your own products, codes and trade lanes, whether you import, export or both, and drafts the update to your compliance program for your approval. Nothing changes without you.
Olivra lists official notices for information only. It is not legal advice, and Olive is not a lawyer or a licensed customs broker. The official text at the source is what counts.